Agenda – European Neurotech Leaders Forum

08:15–08:45

Introductions and Welcome

James Cavuoto, Editor and Publisher, Neurotech Reports

Paru Deshpande, Ph.D., Vice President, R&D, Health Technologies, imec

08:45–09:30

State of the European Neurotechnology Industry, 2026

James Cavuoto, Editor and Publisher, Neurotech Reports

Neurotech Business Report Editor James Cavuoto provides his insights and observations on the state of the European neurotechnology industry. He surveys changes in the competitive landscape that have occurred over the years, the most significant events of the last year, and challenges confronting the industry in years ahead.

09:30-10:15

Keynote Address

Thomas Stieglitz, Ph.D., Professor, University of Freiburg

A European neurotechnology pioneer offers his views on future directions in the industry.

10:15–10:45

Coffee Break

10:45–11:30

Neuromodulation Technology Advances

Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator

Will Pitkin, Senior Director of Business Development and Neuromodulation Strategy, Cirtec Medical

Rob Crawford, Senior Director of Sales and Marketing, MST

Omari Bouknight, CEO, Resonant Link Medical

Thorsten Göettsche, CTO, Osypka

In this session, we’ll look at how new technology is changing the competitive landscape in the neuromodulation industry. Panelists will discuss advances in wireless energy delivery, flexible leads, and nanoparticles.

11:30-12:15

Entrepreneur Panel I

James Cavuoto, Editor, Neurotech Reports, Moderator

Bert Monna, Ph.D., CTO, Phosphoenix B.V.

Karl Stoklosa, CEO, Precisis GmbH

Mark Caffrey, CEO, Syntropic Medical

This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm’s technology and markets.

12:15–13:30

Luncheon

13:30-14:15

FemTech Meets Neurotech: An Underserved Market with Real TAM

JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator

Daniel Chew, Ph.D., CEO and Co-founder, Artemis Medical

Hubert Martens, Ph.D., CEO, Salvia Bioelectronics

In this session, panelists will discuss new opportunities for neurotech devices in women’s health. Among the applications are pelvic pain, endometriosis, and menopause-linked disorders.

14:15-15:00

From Neurotechnology Discovery to Clinical-Scale Systems

Carolina Mora Lopez, Ph.D., Scientific Director of Neurotech, imec

An imec technology leader offers an overview of the evolution of neurotechnology at imec, from Neuropixels to current high-density ASICs, highlighting platform development over time.

15:00-15:30

Refreshment Break

15:30-16:15

BCI Leaders of Europe

JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator

Fabien Sauter, Ph.D., Project Manager, CEA Clinatec

Dorian Haci. CEO and Co-Founder, Mint Neurotechnologies

Willem Koenders, Head of Commercialization, INBRAIN Neuroelectronics

JoJo Platt moderates a panel with some of Europe’s leading commercial firms pursuing the market for brain-computer interfaces.

16:30-17:30

Lab and Cleanroom Tours

17:30–20:00

Networking Reception

08:30–08:45

Introductions and Welcome

08:45–09:30

Venture Capital Investment: What’s Getting Funded?

James Cavuoto, Editor, Neurotech Reports, Moderator

Diana Saraceni, Co-founder and Managing Partner, Panakes Partners

Ugo Tomasello, Ph.D., Co-founder and General Partner, European BrainTech Fund

Mario Huyghe, Senior Venture Development Manager, imec

Jan Debets, Head of Business Development & Partnerships, META Group

Neurotech Business Report Editor James Cavuoto moderates a panel with leading venture capital firms active in Europe that fund neurotechnology ventures. Panelists will discuss factors such capital efficiency, platform narratives, and determining valuations.

09:30-10:15

Regulatory Divergence is Now a Strategy Choice

Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator

Jacek Eisler, Neuro Market Segment Manager, TUV SUD

Lindsey Jardine, Vice President, Clinical, Regulatory, Quality Affairs, Adraxe

Martin Becker, Neuro Market Segment Manager, cpi

In this session, panelists will discuss important regulatory decisions that neurotech firms must make, including the timing of FDA vs. CE Mark applications, updates on EU MDR policies, and the value of pursuing breakthrough device designation.

10:15–10:45

Coffee Break

10:45–11:30

Neurotech Europe on the World Stage: Strategy, Scale, and Global Integration

JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator

Mark Vlek de Coningh, Secretary General, Neurotech EU

François Véron, General Partner, Newfund

Stephen Hicks, Science and Technology Lead, ARIA

Europe’s neurotechnology sector has reached a critical inflection point. While rich in scientific talent and early innovation, there are still opportunities for growth in scale, capital efficiency, and global market influence. This session brings together leaders from across Europe to examine what’s working, what’s broken, and where Europe risks falling behind. The discussion will focus on levers for growth including regulatory alignment, reimbursement pathways, capital formation, and industry coordination in order to position Europe as a competitive, globally integrated neurotech powerhouse.

11:30-12:15

Entrepreneur Panel II

James Cavuoto, Editor, Neurotech Reports, Moderator

Olivier Menage, D. Pharm, CEO, Stimalia

Luca Ravagnan, Ph.D., CEO and Co-founder, WISE

Eliot Frazier, CEO, SONA

This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm’s technology and markets.

12:15–13:30

Luncheon

13:30-14:15

Entrepreneur Panel III

Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator

Frederik Ceyssens, CEO, ReVision Implant

Michael Pare, CEO, Melora Medical

Stéphane Corp, CEO, Deep Pulse Neuro

This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm’s technology and markets.

14:15-15:00

Beyond the Brain: Peripheral, Autonomic, and Systemic Control

Victor Pikov, Contributing Editor, Neurotech Reports, Moderator

Sean Doherty, Ph.D., Director of R&D, Amber Therapeutics

Jiande Chen, Ph.D., Director of Neuromodulation, Division of Gastroenterology, University of Michigan

Omar Shalby, CEO and Co-founder, Neurovia Srl

In this session, we look at applications of neuromodulation beyond the central nervous system, including therapies for treating systemic and end-organ disorders. Panelists will discuss new closed-loop vagus nerve and pelvic neuromodulation trends and new reimbursement developments.

15:00-15:30

Refreshment Break

15:30-16:15

Enabling Neuromodulation Research with Advanced Stimulation & Closed Loop Paradigms

In this session, an imec executive offers an overview of recent advances in neuromodulation technologies at imec, highlighting neural stimulation approaches and closed-loop paradigms for next-generation brain–technology interfaces.

Vojkan Mihajlovic, Ph.D., Principal Scientist, imec

16:15-17:15

Closing Remarks